Axogen Inc. logo

AXGN

Axogen Inc.

$10.65

Earnings Summary

Revenue
$34.45Mn
Net Profits
$-7.74Mn
Net Profit Margins
-22.46%

Highlights

Revenue:

Axogen Inc.’s revenue jumped 2.6% since last year same period to $34.45Mn in the Q2 2022. On a quarterly growth basis, Axogen Inc. has generated 11.12% jump in its revenue since last 3-months.

Net Profits:

Axogen Inc.’s net profit jumped 2% since last year same period to $-7.74Mn in the Q2 2022. On a quarterly growth basis, Axogen Inc. has generated 32.55% jump in its net profits since last 3-months.

Net Profit Margins:

Axogen Inc.’s net profit margin jumped 4.49% since last year same period to -22.46% in the Q2 2022. On a quarterly growth basis, Axogen Inc. has generated 39.3% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Axogen Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-0.14
EPS Estimate Current Year
-0.14

Highlights

EPS Estimate Current Quarter:

Axogen Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.14 - a 6.67% jump from last quarter’s estimates.

EPS Estimate Current Year:

Axogen Inc.’s earning per share (EPS) estimates for the current year stand at -0.14.

Key Ratios

Key ratios of the Axogen Inc. post its Q2 2022 earnings

Earning Per Share (EPS)
-0.06
Return on Assets (ROA)
-0.1
Return on Equity (ROE)
-0.29
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Axogen Inc.’s earning per share (EPS) jumped 33.33% since last year same period to -0.06 in the Q2 2022. This indicates that the Axogen Inc. has generated 33.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Axogen Inc.’s return on assets (ROA) stands at -0.1.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Axogen Inc.’s return on equity (ROE) stands at -0.29.

Dividend Per Share (DPS):

Axogen Inc. declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-06-30
-0.14
-0.06
57.14%
2022-05-05
-0.15
-0.2
-33.33%

Company Information

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.

Organisation
Axogen Inc.
Employees
357
Industry
Health Technology